Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital

Study ID: NCT05558943
Start Date: 2025-10
End Date: 2030-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

750

Intervention / Treatment
Sponsor

Public assistance - Paris hospitals

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer

Study ID: NCT07133425
Start Date: 2026-02-05
End Date: 2030-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

29

Intervention / Treatment

SAR445877

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Multimodal Ultrasound in Peripheral Neuropathy

Study ID: NCT06711133
Start Date: 2025-10
End Date: 2026-01-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Evolution of Tissue Perfusion and Venous Congestion Markers in Fluid-Responsive Septic Shock Patients

Study ID: NCT06958809
Start Date: 2026-02-01
End Date: 2027-08-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Echography

Sponsor

Hospital Ambroise Paré Paris

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Study ID: NCT07123415
Start Date: 2025-10
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

110

Intervention / Treatment

Abix-343 a

Pembrolizumab

Sponsor

Aptabio Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Study ID: NCT05467748
Start Date: 2025-10-13
End Date: 2029-10-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

66

Intervention / Treatment

Tulimimetostat

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Bumetanide vs. Furosemide in Cirrhosis

Study ID: NCT06941415
Start Date: 2025-10-01
End Date: 2027-10-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

500

Intervention / Treatment

Bumetanide

Furosemide

Sponsor

Stacy Johnson

Source: clinicaltrials.gov

Share:
Add to list

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People Living With HIV Receiving Antiretroviral Therapy

Study ID: NCT06819176
Start Date: 2025-10-01
End Date: 2029-01-24
Study Type

Interventional

Study Phase

Phase1

No. of Participants

50

Intervention / Treatment

Lenkavir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list

Effects of Postbiotics on Mood Disorders in Korean Adults

Study ID: NCT06982599
Start Date: 2025-10-13
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

52

Intervention / Treatment

postbiotics

placebo

Sponsor

University

Source: clinicaltrials.gov

Share:
Add to list

The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature

Study ID: NCT05067998
Start Date: 2025-12-21
End Date: 2026-09-17
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

IV Vitamin Infused Therapy Treatment

Herbal medicine

Sponsor

Faith A. Richardson

Source: clinicaltrials.gov

Share:
Add to list